Apple earnings, Eli Lilly, ConocoPhillips: 3 things to watch

Go back to Apple earnings, Eli Lilly, ConocoPhillips: 3 things to watch

Citi continue to see upside to Eli Lilly & Co.'s (LLY) 'already rich' valuation

November 2, 2023 11:11 AM EDT

Citi analyst Andrew Baum said in a note Thursday that the Mounjaro beat for Eli Lilly & Co. (NYSE: LLY) goes on after the companys solid third-quarter results, which were boosted by the drug.

Baum reiterated a Buy rating and $675 price... More